Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Directorate Change

25 Jun 2018 07:03

RNS Number : 3043S
Standard Life Aberdeen plc
22 June 2018
 

Standard Life Aberdeen plc

 

Board change

 

The Board of Standard Life Aberdeen plc ('SLA') announces that Cathleen Raffaeli will be appointed as a Non-Executive Director with effect from 1 August 2018.

 

Commenting on her appointment, Sir Gerry Grimstone, Chairman of SLA, said:

 

"I am delighted that Cathi has agreed to join our Board. Her strong FinTech experience and background in the platforms sector, as well as her board experience, make her an ideal addition as we continue to build a world class investment company".

 

At the same time as she joins the Board, Cathleen Raffaeli will be appointed as a member of the Remuneration Committee.

 

Following this appointment, the Board will comprise four executive directors, nine non-executive directors and the Chairman. The Board will be made up of three women and eleven men. The restructuring of the Board after the merger in 2017 will continue over the coming months. The Financial Conduct Authority and the Prudential Regulation Authority have been notified of this appointment. Cathleen Raffaeli's other appointments are listed below and no other information is required to be disclosed pursuant to paragraph LR 9.6.13R of the Listing Rules of the Financial Conduct Authority.

 

The Board also notes the announcement this morning by the Board of Phoenix Group Holdings ('PGH') of the proposed appointment of Barry O'Dwyer and Campbell Fleming as Non-Executive Directors of PGH. These appointments will be effective from the date of completion of the acquisition by Phoenix Group of SLA's UK and European insurance business and are being made pursuant to nomination by SLA in accordance with the terms of its contractual arrangements with PGH.

 

Barry O'Dwyer is the CEO of SLA's Pensions & Savings business (Standard Life). Barry has held several senior roles at Standard Life since re-joining the company in 2013, and during his initial spell at Standard Life between 1988-2008. A fellow of the Institute of Actuaries, Barry has 30 years of experience in the insurance industry, in a career which has also included senior roles at Prudential and HBOS.

 

Campbell Fleming is the Global Head of Distribution at Aberdeen Standard Investments, the asset management business of SLA. He joined Aberdeen Asset Management in August 2016 from Columbia Threadneedle Investments where he was the Chief Executive - EMEA and Global COO. Campbell is the Chair of the Investment Association Trade Committee and previously held senior positions at JP Morgan Asset Management.

 

25 June 2018

Enquiries:

Media: Katy Hetherington

+44 (0) 131 245 2283*

+44 (0) 7841 344 374

 

Institutional Equity Investors: Jakub Rosochowski

+44 (0) 131 245 8028*

+44 (0) 7515 298 608

 

Group Secretariat: Paul McKenna

+44 (0) 131 245 1168*

 

 

* Calls may be monitored and/or recorded to protect both you and us and help with our training. Call charges will vary.

 

END

 

LEI number of Standard Life Aberdeen plc: 0TMBS544NMO7GLCE7H90

Classification: 3.1. Additional regulated information required to be disclosed under the laws of a Member State

 

 

Notes to Editors

 

Cathleen Raffaeli

 

Non-Executive Director's Fee

 

Cathleen Raffaeli's fee as a Non-Executive Director of SLA will be £73,500 per annum.

 

Interest in shares

 

As at the date of her appointment, Cathleen Raffaeli does not hold any shares in Standard Life Aberdeen plc.

 

Biographical details:

Nationality:

American

Education/Qualifications:

New York University, MBA (1988)

University of Baltimore, BS, (1979)

Other Non-Executive Appointments:

2007 - Present

Federal Home Loan Bank of New York

Non-Executive Director

Previous Non-Executive and Advisory Roles:

2014-2016

2003-2011

1998-2008

Kapitall Holdings

 

E\* Trade Financial

 

American Home Mortgage Investment

Career summary:

2002-Present

Hamilton White Group and Soho Venture Partners

Managing Partner

2000-2002

ProAct Technologies

President and Chief Executive Officer

1998-2000

CFN

Chief Executive Officer

1994-1998

Citicorp

Various commercial, transaction and mortgage roles

1988-1994

Chemical Bank

Various commercial, transaction and mortgage roles

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGUPGQUPRGAP
Date   Source Headline
24th Feb 20262:25 pmRNSChange of Company Name
18th Feb 20262:12 pmRNSAppointment of Corporate Broker
6th Feb 20261:52 pmRNSDirector/PDMR Shareholding
2nd Feb 202611:02 amRNSTotal Voting Rights
6th Jan 20261:31 pmRNSDirector/PDMR Shareholding
2nd Jan 202611:06 amRNSTotal Voting Rights
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
12th Dec 20252:49 pmRNSBlock listing Return
8th Dec 202511:08 amRNSDirector/PDMR Shareholding
1st Dec 20251:57 pmRNSTotal Voting Rights
24th Nov 20255:20 pmRNSBlock Listing Application
24th Nov 20257:09 amRNSLIST 2025 Results Show Robust Capital Position
6th Nov 20253:47 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:01 pmRNSTotal Voting Rights
31st Oct 20253:10 pmRNSDirector/PDMR Shareholding
7th Oct 20251:20 pmRNSDirector/PDMR Shareholding
1st Oct 202512:38 pmRNSTotal Voting Rights
17th Sep 20252:40 pmRNSPublication of a Supplementary Prospectus
10th Sep 20252:51 pmRNSDirector/PDMR Shareholding
8th Sep 20255:23 pmRNSDirector/PDMR Shareholding
8th Sep 20257:00 amRNS2025 Interim Results
1st Sep 202510:00 amRNSTotal Voting Rights
18th Aug 202510:00 amRNSBoard Changes
6th Aug 202512:53 pmRNSDirector/PDMR Shareholding
1st Aug 202510:18 amRNSTotal Voting Rights
8th Jul 20253:31 pmRNSDirector/PDMR Shareholding
1st Jul 202512:26 pmRNSTotal Voting Rights
26th Jun 20259:00 amRNSBoard Changes
13th Jun 20253:00 pmRNSPublication of Prospectus
12th Jun 20252:43 pmRNSBlock listing Return
9th Jun 202512:25 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:44 pmRNSTotal Voting Rights
23rd May 20253:02 pmRNSDirector/PDMR Shareholding
20th May 202510:00 amRNSDirector Declaration
13th May 20253:34 pmRNSResult of AGM
7th May 20254:20 pmRNSDirector/PDMR Shareholding
1st May 202510:33 amRNSTotal Voting Rights
10th Apr 20252:37 pmRNSDirector/PDMR Shareholding
8th Apr 20253:10 pmRNSDirector/PDMR Shareholding
3rd Apr 20251:35 pmRNSNotice of AGM
1st Apr 20252:52 pmRNSDirector/PDMR Shareholding
1st Apr 20252:42 pmRNSTotal Voting Rights
26th Mar 20253:46 pmRNSDirector/PDMR Shareholding
24th Mar 20255:43 pmRNSDirector/PDMR Shareholding
21st Mar 202511:56 amRNSDirector/PDMR Shareholding
20th Mar 20254:19 pmRNSDirector/PDMR Shareholding
19th Mar 20254:26 pmRNSDirector/PDMR Shareholding
19th Mar 20252:15 pmRNSDirector/PDMR Shareholding
17th Mar 20257:00 amRNS2024 Annual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.